European bioregions : strengths and partnership strategies. The - - PowerPoint PPT Presentation

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

European bioregions : strengths and partnership

• strategies. The bioXclusters example

BioPartnering Latin America – cluster forum – september 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

Contents Who we are Our goals Our activities Wha we can offer What we will represent in the future

23 April, 2013

2

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

 mutual learning  exchange of good practice  joint business opportunities  development of common strategies  exchange of qualified staff  mobility of firms  sharing incubation facilities  mutually sharing access to networks and international partnerships  access to international markets and business development in new market  mutually exchange technical competences  share research infrastructure and production facilities  economies of scale

Why to cooperate?

May 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters May 2013 4

bioXclusters

Regional clusters partnership

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters 5

Who are we?

bioXclusters is a European initiative, funded by the European Commission, uniting 4 regions in Europe with one single approach: Supporting the competitiveness of European clusters’ SMEs by facilitating internationalisation and access to global markets

May 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

May 2013

6

Our assets

MAIN SECTORS

Biotechnology Health care Biomedicine Regenerative Med. Biopharmaceutical Diagnostics

THERAPEUTIC AREAS

Oncology Cardiovascular Infectious diseases Inflamatory diseases Neurological diseases Autoimmune diseases

TECHNOLOGY SPECIALITIES

Personalised Medicine Nanomedicine Targeted therapies Drug Development Medical technologies Diagnostics Solutions

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters May 2013 7

Four European partners

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

The Bioregion of Catalonia

• Main biotech hub in

Spain

• 480 companies
• 435 Research Groups
• 10 Universities
• 3 Large-scale R&D

Infrastructures

• 15 university hospitals
• 20 Science parks

Visit us in www.biocat.cat Follow us on twitter (@biocat.en) and Linkedin

Catalonia (Spain) with capital in Barcelona

INTERNATIONALIZATION/GLOBALIZATION:

Facilitating access to markets through:

• Network of local contacts in foreign markets
• Agreements with science parks and other
• rganizations

Main Interests:

• USA
• Asia (China, Japan & India)
• South America

Member of CEBR – Council of European Bioregions & EDCA

Main Therapeutic Areas

• Oncology
• Neurosciences
• Cardiovascular
• Dermatology

Technological Strengths

• Nanobiomedicine
• Genomics &

Structural Biology

• Drug Design
• Bioinformatics

Fostering talent

www.moebio.org

Organization of BIoEurope Spring 2010 & 2013

1997 – Barcelona Science Park was created 2006 – Creation of Biocat – Private Foundation Promotes and develops life sciences in Catalonia 2013 – Launch of the First Edition of Design Health Barcelona program

d·HEALTH Barcelona

May 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

Bavaria (Germany) and Greater Munich

1989 - Foundation of first biotech SME 1997- Establishment of BioM cluster organisation 2010 – Start of Munich Initiative for Personalized Medicine (www.m4.de) 338 biotech & pharma companies:

178 biotech SMEs 37 biotech non-SMEs 37 pharma companies 86 CROs & suppliers

26.000 employees in total, 4.300 in biotech SMEs

INTERNATIONALIZATION / GLOBALIZATION: Growth through partnerships and collaborations in Europe and worldwide. Main interest of members: Asia (China & Japan) and USA Member of CEBR – Council of European Bioregions

BioM Biotech Cluster Development GmbH

www.bio-m.org

Personalised Medicine & Targeted Therapies, Therapeutics & Diagnostics, Devices, Analytics, Informatics Oncology, Cardiovascular diseases Autoimmune diseases Close collaboration with regional medtech network

“m4 Initiative for Personalized Medicine & Targeted Therapies”:

100 mio € for 5 years, 35 R&D projects, 5 infrastructure projects, m4 Award for start-ups, collaborations between SMEs and academia / hospitals.

Germany

May 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

Piemonte region (Italy) Main city Torino (Turin)

1999- Science park creation 2009-Cluster initiative inception 400-in total 270 health care 7.000 employees SME No: 95% 27 MNC 3900 scientist in R&D institutions

INTERNATIONALIZATION/GLOBALIZATION: Growth through partnerships and collaborations

14+ MOU with international actors 147 SMEs supported (last 4 years) 10+ international projects ongoing and realized

CEBR – Council of European Bioregions 2 Multinational corporations as shareholder of the science park Metaclustering approach to have critical mass based on complementarities bioPmed health care cluster Bioindustry Park Silvano Fumero SpA Science park www.biopmed.eu www.bioindustrypark.eu

• Personalised health

care/Converging technologies

• Innovative biomedical

devices (Prosthesis)

• Imaging
• Regenerative

medicine

• Oncology, CNS,

Autoimmune diseases

• Start-up creation

ALISEI Member Bioeurope Spring 2014 in Torino 30 R&D projects launched involving 70 actors in the last 4 years

May 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

LYONBIOPOLE

Rhone-Alpes BioCluster www.lyonbiopole.com

Rhone-Alpes Region (France) Main cities Lyon & Grenoble

+ 500 companies in health care + 30 000 employees + 4 000 scientists >4 World Class leaders: bioMérieux, Sanofi, BD, Merial. >8 International R&D Infrastructures >130 official members > 134 R&D projects = total of € 667 million

INTERNATIONALIZATION/GLOBALIZATION: >Internationalization based on a dual approach: interclustering and support to SMEs. >3 main target markets: North America (USA + Canada), Brazil & China >One representative based in Shanghai >Member of CEBR – Council of European Bioregions & EDCA >In 2012: + 50 companies supported & 6 international trade missions

Infectious diseases Immune Disorders Cancers Personalized medicine Biotherapies & Vaccines Diagnostics Delivery systems Devices Close collaboration with regional medtech network

European Network on System Biology & Medicine

>2005 – Establishment

• f the French cluster

policy and creation of Lyonbiopole >2012 – EU Bronze Label Awarded and Lyonbiopole assessed as the most performing French BioCluster

7 500 sq.m of biomanufacturing & bioanalysis labs

1 920sq.m of BSL 2/3 Labs Technological Research Institute on Infectious Diseases & Microbiology May 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters 12

Our goals and activities

May 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

13

Brazil China US

With 2 main objectives…

3 target markets…

Supporting European SMEs’ internationalisation and creating a single European entry point for global biotech & health players

May 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

 Hosting Eduardo Soares, CEO of Biominas (Minas Gerais), in Europe (April 2012)  1 country report (Sept 2012)  Mission to Sao Paulo & Rio de Janeiro (Sept 2012) Institut Butantan, CIETEC, FAPESP, FioCruz, BIORIO, Recepta, Pitanga, FINEP Participation in BioPartnering Latin America 2012  Signature of an MoU for 2 years with Health Foundation and Technological Park of Ribeirão Preto region, Brazil (March 25, 2013)  Signature with MOU with Biorio (September 2013)  Mission with European Commission (Sept 2013). Participation in BioPartnering Latin America 2013

Main activities and achievements up to now

14

Brazil China US

 Hosting Gao Ronghui, CEO of G-med Consulting (Shanghai), in Europe (Jan 2013)  1 country report (Jan 2013)  Mission to Shanghai region, with around 15 EU companies from 4 countries (May 2013): Co-organisation of a Sino-European Partnering Day Participation in BioForum conference and visits (parks, hospitals, companies) Signatures of MoUs with Zhangjiang Park + Juke Biotech Park  Hosting Karin Hollerbach, CEO Taku Group (Silicon Valley) in Europe (April 2013)  1 country report in progress (September 2013)  Mission with EU companies planned (October 2013)

May 2013

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters May 2013 15

What can we offer?

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

What can we offer?

May 2013

16

bioXclusters, a unique metacluster, your entry point to access the European healthcare market  Expertise on European biotech and medtech market opportunities and regulations  Access to high quality innovative players (SMEs & academic research partners)  Collaboration potential in many innovative R&D and drug development projects  High-tech solutions for the Chinese healthcare market Activities are realised in complementarity

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters May 2013 17

Building win-win exchanges

Providing European market key data and knowing better foreign markets Supporting European SMEs to reach target markets, create new technological and commercial reciprocal opportunities Identifying new partners between respective countries’ players (companies, academics, clusters) Building long-term relations between European clusters and foreign counterparts

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

bioXclusters contact details

May 2013

20

Emilie Romeo

Project manager emilie.romeo@lyonbiopol e.com +33 (0)4 72 76 53 30 www.lyonbiopole.com

• Dr. Daniela Tonn

International Affairs & Training tonn@bio-m.org +49 (0)89 89 96 79 15 www.bio-m.org

Fabrizio Conicella

Director Business Development and Internation Projects conicella@bioindustry park.it +39(0) 125 561.311 www.biopmed.eu

Elisabetta Schena

International Cluster Development Project Manager elisabetta.schena@erai.org +33 (0)4 26 73 68 04 www.erai.org

Mamen Marti

Head of Internationalisation (Business Development) cmarti@biocat.cat +34 (0)93 3103330 www.biocat.cat

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

EU Initiative Promoting SME Internationalisation Through Clusters

Thank you for your attention

Visit us at www.bioXclusters.eu Follow us on Twitter (@bioXclusters) and Linkedin

This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)

Partners: Coordinated by:

May 2013